You are here: Industry Insights > COVID-19

News List

Government-funded Centre for Biopharma Analysis set up in Pune expresspharma
August 17, 2020
It has numerous high-end instrumentation facilities worth Rs 10 crore and is expected to fast track research under biopharma in the country.
COVID-19 disrupted clinical trials with suspended enrollment more likely to resume: GlobalData expresspharma
August 17, 2020
The number of trials that have been impacted by slow enrollment has increased by 13.9 per cent.
Scientists ascertain 73 novel variants of COVID-19 strain in Odisha expresspharma
August 17, 2020
The research team, which carried out sequencing of 1,536 samples including 752 clinical samples, reported two lineages -- B.1.112 and B.1.99 -- for the first time in India, informed lead investigator.
Preliminary study of 300+ COVID-19 patients suggests convalescent plasma therapy effective worldpharmanews
August 14, 2020
A preliminary analysis of an ongoing study of more than 300 COVID-19 patients treated with convalescent plasma therapy at Houston Methodist suggests the treatment is safe and effective.
SAB begins phase 1 trial of Covid-19 therapeutic candidate SAB-185 pharmaceutical-business-review
August 14, 2020
SAB Biotherapeutics, a US-based clinical-stage company, has dosed the first participant of a phase 1 study of SAB-185, its therapeutic candidate for Covid-19, in healthy volunteers.
ANA Therapeutics Partners with Quotient Sciences contractpharma
August 14, 2020
Will manufacture ANA001 as a potential treatment for COVID-19.
MHRA announces recall of Randox COVID-19 testing kits in UK europeanpharmaceuticalreview
August 14, 2020
Randox is recalling COVID-19 testing kits in the UK as a precautionary measure as they do not meet the required safety standards, the MHRA has said.
SAB Receives $35.6 Miliion from U.S. DOD contractpharma
August 14, 2020
SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a proprietary technology to produce fully human polyclonal antibodies without the need for human donors, has been awarded an additional $35.6 million in expanded scope for its ...
Scientists leverage AI to find COVID-19 drug candidates expresspharma
August 14, 2020
They identified the best-in-class hits for the 65 human proteins that interact with SARS-CoV-2 proteins.
Omeros reports positive results for Narsoplimab in treatment of Covid-19-associated ARDS pharmaceutical-business-review
August 13, 2020
Omeros Corporation reported the results of a compassionate-use study evaluating narsoplimab, Omeros’ investigational human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2) ...